These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 32825063)
1. The Sialoside-Binding Pocket of SARS-CoV-2 Spike Glycoprotein Structurally Resembles MERS-CoV. Awasthi M; Gulati S; Sarkar DP; Tiwari S; Kateriya S; Ranjan P; Verma SK Viruses; 2020 Aug; 12(9):. PubMed ID: 32825063 [TBL] [Abstract][Full Text] [Related]
2. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Behloul N; Baha S; Shi R; Meng J Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235 [TBL] [Abstract][Full Text] [Related]
3. The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint. Guo H; Li A; Lin HF; Liu MQ; Chen J; Jiang TT; Li B; Wang Y; Letko MC; Peng W; Shi ZL J Virol; 2022 Aug; 96(15):e0095822. PubMed ID: 35852351 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of Coronavirus Entry Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M mBio; 2020 Oct; 11(5):. PubMed ID: 33082259 [TBL] [Abstract][Full Text] [Related]
5. Structures of MERS-CoV spike glycoprotein in complex with sialoside attachment receptors. Park YJ; Walls AC; Wang Z; Sauer MM; Li W; Tortorici MA; Bosch BJ; DiMaio F; Veesler D Nat Struct Mol Biol; 2019 Dec; 26(12):1151-1157. PubMed ID: 31792450 [TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Evolutionary Adaptation toward Host Entry and Recognition of Receptor O-Acetyl Sialylation in Virus-Host Interaction. Kim CH Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32604730 [TBL] [Abstract][Full Text] [Related]
7. Examining sialic acid derivatives as potential inhibitors of SARS-CoV-2 spike protein receptor binding domain. Banerjee T; Gosai A; Yousefi N; Garibay OO; Seal S; Balasubramanian G J Biomol Struct Dyn; 2024 Aug; 42(12):6342-6358. PubMed ID: 37424217 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S Elife; 2020 Oct; 9():. PubMed ID: 33103998 [TBL] [Abstract][Full Text] [Related]
9. Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Lan J; Ge J; Yu J; Shan S; Zhou H; Fan S; Zhang Q; Shi X; Wang Q; Zhang L; Wang X Nature; 2020 May; 581(7807):215-220. PubMed ID: 32225176 [TBL] [Abstract][Full Text] [Related]
10. Distinct Roles for Sialoside and Protein Receptors in Coronavirus Infection. Qing E; Hantak M; Perlman S; Gallagher T mBio; 2020 Feb; 11(1):. PubMed ID: 32047128 [TBL] [Abstract][Full Text] [Related]
11. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Letko M; Marzi A; Munster V Nat Microbiol; 2020 Apr; 5(4):562-569. PubMed ID: 32094589 [TBL] [Abstract][Full Text] [Related]
12. Key residues of the receptor binding motif in the spike protein of SARS-CoV-2 that interact with ACE2 and neutralizing antibodies. Yi C; Sun X; Ye J; Ding L; Liu M; Yang Z; Lu X; Zhang Y; Ma L; Gu W; Qu A; Xu J; Shi Z; Ling Z; Sun B Cell Mol Immunol; 2020 Jun; 17(6):621-630. PubMed ID: 32415260 [TBL] [Abstract][Full Text] [Related]
13. Exploring the intrinsic dynamics of SARS-CoV-2, SARS-CoV and MERS-CoV spike glycoprotein through normal mode analysis using anisotropic network model. Majumder S; Chaudhuri D; Datta J; Giri K J Mol Graph Model; 2021 Jan; 102():107778. PubMed ID: 33099199 [TBL] [Abstract][Full Text] [Related]
14. Ca Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925 [TBL] [Abstract][Full Text] [Related]
15. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
16. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. CorrĂȘa Giron C; Laaksonen A; Barroso da Silva FL Virus Res; 2020 Aug; 285():198021. PubMed ID: 32416259 [TBL] [Abstract][Full Text] [Related]
17. Computational designing of a peptide that potentially blocks the entry of SARS-CoV, SARS-CoV-2 and MERS-CoV. V K P; Rath SP; Abraham P PLoS One; 2021; 16(5):e0251913. PubMed ID: 34003827 [TBL] [Abstract][Full Text] [Related]
18. Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2. Zhang XY; Huang HJ; Zhuang DL; Nasser MI; Yang MH; Zhu P; Zhao MY Infect Dis Poverty; 2020 Jul; 9(1):99. PubMed ID: 32690096 [TBL] [Abstract][Full Text] [Related]
19. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors. Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913 [TBL] [Abstract][Full Text] [Related]
20. Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. Song W; Gui M; Wang X; Xiang Y PLoS Pathog; 2018 Aug; 14(8):e1007236. PubMed ID: 30102747 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]